Trials / Completed
CompletedNCT04920656
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- King Hussein Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to examinethe pattern and frequency of pathogenic variants among all newly diagnosed breast cancer patients in a genetically distinct population. Additionally, the uptake rate of "cascade family screening" , frequency of pathogenic variants and barriers against testing will be studied.
Conditions
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2021-06-10
- Last updated
- 2025-03-19
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04920656. Inclusion in this directory is not an endorsement.